Zyvex Continues to Exceed Sales Expectations

Nanotechnology Company Exceeds $2.9 Million in Q1 2006 Sales

Apr 19, 2006, 01:00 ET from Zyvex Corporation

    RICHARDSON, Texas, April 19 /PRNewswire/ -- Zyvex today announced
 financial results for its fiscal 2006 first quarter. The Texas company
 continues its business gains with total revenues for the quarter totaling
 $2,956,582 -- a 45 percent increase over the same period in 2005.
     "Our first quarter exceeded expectations," said Zyvex CFO Timothy M.
 Gilmore. "These financial results are a direct effect of our consistent
 execution to our strategic plan and our continued goal of delivering value
 to our customers."
     "We are totally committed to long-term product innovation and customer
 value," said Zyvex President Dr. Thomas A. Cellucci. "Our financial
 successes over the past five years are a reflection of our strong IP
 position and our customer's loyalty and passion for our products' value,
 quality, and performance."
     This month, Zyvex also introduced its L200 Nanomanipulator for the Life
 Science arena. Researchers can use the L200 for cellular manipulation,
 biomaterials characterization, patch-clamping, micro-injection, and intra-
 and extra cellular probing. The company also released the F100-TSP
 Nanomanipulator for TEM Sample Lift-out.
     Founded in 1997, Zyvex reported its first revenues in 2001, grossing
 $150,000. Company revenues grew to $1.2 Million in 2002, $4.3 Million in
 2003, $8.6 Million in 2004, and $10.3 Million in 2005. The Zyvex team
 anticipates that the company will achieve cash-flow break-even during 2006.
 The company has an impressive patent portfolio with 32 U.S. Patents (with
 another 32 pending), and 6 International Patents (with another 52 pending).
     Zyvex has customers in the Aerospace/Defense, Healthcare/Medical, and
 Electronics/Semiconductor industries. Zyvex has numerous key alliances with
 industry leaders, including Easton Sports, Frost & Sullivan, MIT's
 Institute for Soldier Nanotechnologies, and Texas Instruments.
     Zyvex has worldwide sales representation in Australia, China, France,
 Germany, Italy, Japan, Korea, Malaysia, New Zealand, Poland, Singapore,
 Spain, Switzerland, Taiwan, Thailand, the United Kingdom, and Vietnam
 through alliances with Keithley Instruments, Inc., Caltron, Pte., Coherent
 Scientific Pty Ltd., and L.O.T.-Oriel.
     About the Company
     Zyvex Corporation, based in Richardson, Texas, is the first molecular
 nanotechnology company. Zyvex's vision is to be the leading worldwide
 supplier of tools, products, and services that enable adaptable,
 affordable, and molecularly precise manufacturing. Zyvex commercializes
 nanotechnology to address real-world applications with high growth
 potential. Zyvex carries its scientific breakthroughs into key commercial
 applications in the area of materials, tools, and structures.

SOURCE Zyvex Corporation